HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IFF

This article was originally published in The Rose Sheet

Executive Summary

North American fragrance sales declined 1% in 2005, but fine fragrance revenues in the region increased 4%, International Flavors & Fragrances reports Jan. 25. For the year, North American sales declined 4%. IFF worldwide net sales for the year were down 2% on a reported basis to $1.99 bil., negatively impacted by the disposition of the company's European fruit preps business, firm notes. Net earnings also fell 2% to $193.1 mil., but improved 3% excluding restructuring and other charges, according to IFF. In Q4, fragrance net sales in North America declined 1%, while fine fragrances increased 16%. Net sales fell 1% on a reported basis to $461.6 mil., while net income plummeted 63% to $15.2 mil., largely due to charges related to the recent elimination of 300 positions. IFF continues to seek a replacement for CEO Richard Goldstein, whose retirement was announced Jan. 17, firm notes (1"The Rose Sheet" Jan. 23, 2006, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013672

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel